MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

about

MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

Item

http://www.wikidata.org/entity/Q55518168

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

@en

MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

@nl

type

Item

label

MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

@en

MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

@nl

prefLabel

MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

@en

MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

@nl

P1476

MicroRNA-493 is a prognostic factor in triple-negative breast cancer

@en

P2093

Junjing Li

http://www.w3.org/2001/XMLSchema#string

Ling Yao

http://www.w3.org/2001/XMLSchema#string

Xin Hu

http://www.w3.org/2001/XMLSchema#string

Yanni Huang

http://www.w3.org/2001/XMLSchema#string

Yirong Liu

http://www.w3.org/2001/XMLSchema#string

Zhigang Cao

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer

MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1

Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.

microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers

MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis.

MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1

P304

2294-2301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13644

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Zhiming Shao

P577

2018-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29777630

http://www.w3.org/2001/XMLSchema#string

P921

microRNA

P932

6029816

http://www.w3.org/2001/XMLSchema#string